Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof
The invention relates to a transdermal therapeutic system for the administration of physostigmine onto the skin, composed of a backing layer which is impermeable to the active ingredient, of an active ingredient depot having at least one auxiliary with supportive and distributive function in the for...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.09.1995
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to a transdermal therapeutic system for the administration of physostigmine onto the skin, composed of a backing layer which is impermeable to the active ingredient, of an active ingredient depot having at least one auxiliary with supportive and distributive function in the form of a sheet-like textile material, of a matrix surrounding the latter on all sides and, where appropriate, of a protective layer which can be detached again, the matrix of which contains 10 - 90 % by weight of polymeric material selected from the group consisting of acrylate- and/or methacrylate-based polymers and esters of hydrogenated rosin, 0 - 30 % by weight of plasticisers based on hydrocarbons and/or esters, and the active ingredient depot contains 15 to 85 % by weight of a 0.1 to 70 % by weight physostigmine solution immediately after manufacture. |
---|---|
Bibliography: | Application Number: IE19890004078 |